RECRUITING

Rosacea Radiofrequency Microneedling

Talk to us

Conditions

Rosacea, PapulopustularRosacea, Erythematotelangiectatic

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.

Official Title

Split-Face Comparison of 532nm Potassium Titanyl Phosphate (KTP) Laser Treatment Versus Radiofrequency Microneedling in Combination With 532 KTP Laser for Erythematotelangiectatic or Papulopustular Rosacea

Quick Facts

Study Start:2024-11-01
Study Completion:2026-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06801717

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female adult (\>18yo) subjects in general good health
  2. 2. Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea.
  3. 3. Subject is able to understand and sign informed consent
  4. 4. Subject is able to complete the study and comply with study procedures
  1. 1. Patients currently utilizing oxymetazoline or brimonidine.
  2. 2. Presence of dermatoses that might interfere with diagnosis as determined by a study investigator
  3. 3. Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum
  4. 4. Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
  5. 5. History of poor wound healing or blood-clotting abnormality
  6. 6. History of keloid formation or hypertrophic scarring
  7. 7. Hypersensitivity or contraindication to local anesthetics as determined by the principal investigator or other medical professional.
  8. 8. Prisoners

Contacts and Locations

Study Contact

Maria Muniz Muniz
CONTACT
305-689-2646
mmuniz@med.miami.edu

Principal Investigator

Ariel Eber, MD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami Dermatology Miami Beach Clinic
Miami Beach, Florida, 33128
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Ariel Eber, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-01
Study Completion Date2026-04-01

Study Record Updates

Study Start Date2024-11-01
Study Completion Date2026-04-01

Terms related to this study

Additional Relevant MeSH Terms

  • Rosacea, Papulopustular
  • Rosacea, Erythematotelangiectatic